These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 34675712)

  • 41. Increasing SARS-CoV-2 nucleic acid testing capacity during the COVID-19 epidemic in Beijing: experience from a general hospital.
    Wang Q; Zhao X; Yue Z; Bai X; Rao H; Han N; Wang T; Wang H; Jiang B
    Emerg Microbes Infect; 2020 Dec; 9(1):2358-2360. PubMed ID: 33054582
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip.
    Prazuck T; Colin M; Giachè S; Gubavu C; Seve A; Rzepecki V; Chevereau-Choquet M; Kiani C; Rodot V; Lionnet E; Courtellemont L; Guinard J; Pialoux G; Hocqueloux L
    PLoS One; 2020; 15(9):e0237694. PubMed ID: 32941461
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Saliva as a testing specimen with or without pooling for SARS-CoV-2 detection by multiplex RT-PCR test.
    Sun Q; Li J; Ren H; Pastor L; Loginova Y; Madej R; Taylor K; Wong JK; Zhang Z; Zhang A; Lu CM; Sha MY
    PLoS One; 2021; 16(2):e0243183. PubMed ID: 33621263
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thoracic imaging tests for the diagnosis of COVID-19.
    Islam N; Salameh JP; Leeflang MM; Hooft L; McGrath TA; van der Pol CB; Frank RA; Kazi S; Prager R; Hare SS; Dennie C; Spijker R; Deeks JJ; Dinnes J; Jenniskens K; Korevaar DA; Cohen JF; Van den Bruel A; Takwoingi Y; van de Wijgert J; Wang J; McInnes MD;
    Cochrane Database Syst Rev; 2020 Nov; 11():CD013639. PubMed ID: 33242342
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mass testing after a single suspected or confirmed case of COVID-19 in London care homes, April-May 2020: implications for policy and practice.
    Tang S; Sanchez Perez M; Saavedra-Campos M; Paranthaman K; Myers R; Fok J; Crawley-Boevey E; Dun-Campbell K; Janarthanan R; Fernandez E; Vusirikala A; Patel B; Ma T; Amin-Chowdhury Z; Shetty N; Zambon M; Bell A; Wynne-Evans E; Chow Y; Ladhani S
    Age Ageing; 2021 May; 50(3):649-656. PubMed ID: 33620453
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identifying the effects of an upgraded 'fever clinic' on COVID-19 control and the workload of emergency department: retrospective study in a tertiary hospital in China.
    Wang J; Zong L; Zhang J; Sun H; Harold Walline J; Sun P; Xu S; Li Y; Wang C; Liu J; Li F; Xu J; Li Y; Yu X; Zhu H
    BMJ Open; 2020 Aug; 10(8):e039177. PubMed ID: 32819955
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Response to the COVID-19 Outbreak in The Emergency Department Designed for Emerging Infectious Diseases in Korea.
    Cho SI; Ko JI; Kim Y; Yeo W; Lee K; Cho W; Moon S; Park T
    Infect Chemother; 2021 Mar; 53(1):84-95. PubMed ID: 34409782
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Operational considerations and challenges of biochemistry laboratories during the COVID-19 outbreak: an IFCC global survey.
    Loh TP; Horvath AR; Wang CB; Koch D; Adeli K; Mancini N; Ferrari M; Hawkins R; Sethi S; Lippi G;
    Clin Chem Lab Med; 2020 Aug; 58(9):1441-1449. PubMed ID: 32549122
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of Two Commercial Platforms and a Laboratory-Developed Test for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA.
    Mannonen L; Kallio-Kokko H; Loginov R; Jääskeläinen A; Jokela P; Antikainen J; Väre P; Kekäläinen E; Kurkela S; Jarva H; Lappalainen M
    J Mol Diagn; 2021 Apr; 23(4):407-416. PubMed ID: 33486074
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nucleic acid and antibody assay results in Chinese patients with coronavirus disease 2019 (COVID-19).
    Lu Y; Li Y; Wang Y; Luo J; Yu W
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107089. PubMed ID: 33068863
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients.
    Ling Y; Xu SB; Lin YX; Tian D; Zhu ZQ; Dai FH; Wu F; Song ZG; Huang W; Chen J; Hu BJ; Wang S; Mao EQ; Zhu L; Zhang WH; Lu HZ
    Chin Med J (Engl); 2020 May; 133(9):1039-1043. PubMed ID: 32118639
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radiotherapy workflow and protection procedures during the Coronavirus Disease 2019 (COVID-19) outbreak: Experience of the Hubei Cancer Hospital in Wuhan, China.
    Wei W; Zheng D; Lei Y; Wu S; Verma V; Liu Y; Wei X; Bi J; Hu D; Han G
    Radiother Oncol; 2020 Jul; 148():203-210. PubMed ID: 32342870
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Systematic application of COVID-19 nucleic acid tests in general surgery departments in China: An update of current status with nationwide survey data.
    Pang K; Jin L; Zhang Z
    Int J Surg; 2020 Oct; 82():100-102. PubMed ID: 32827698
    [No Abstract]   [Full Text] [Related]  

  • 55. Improving the detection capability and efficiency of SARS-CoV-2 RNA specimens by the specimen turn-around process with multi-department cooperation.
    Liu C; Shen W; Xie H; Li Y; Cui R; Wu R; Xiao L; Li J; Guo Y; Liao Y; Zhao C; Xu Y; Wang Q
    Front Public Health; 2023; 11():1294341. PubMed ID: 38249400
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Experience of the Fight Against COVID-19 in Clinical Laboratory Departments from Chengdu, China.
    Wang Q; Liu C; Xu J; Song P; Yang S; Zhang Q
    Risk Manag Healthc Policy; 2021; 14():4177-4183. PubMed ID: 34675712
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Role of Fever Clinics in the Strategic Triage of Suspected Cases of Imported COVID-19.
    Jia H; Chang Y; Zhao L; Li Y; Chen L; Zhang Q; Lou X; Li C; Xia S
    Int J Gen Med; 2021; 14():2047-2052. PubMed ID: 34079344
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Emergency surgical workflow and experience of suspected cases of COVID-19: A case report.
    Wu D; Xie TY; Sun XH; Wang XX
    World J Clin Cases; 2020 Nov; 8(21):5361-5370. PubMed ID: 33269271
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Laboratory Biosafety Considerations of SARS-CoV-2 at Biosafety Level 2.
    Wang K; Zhu X; Xu J
    Health Secur; 2020; 18(3):232-236. PubMed ID: 32522074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.